Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Capell

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Pain and Symptom Management|June 1, 2014
Ethical conduct of palliative care research: enhancing communication between investigators and institutional review boardsAmy P Abernethy, Warren H Capell, Noreen M Aziz, et al.
Clinical Trials (London, England)|February 1, 2017
A randomized trial of heart failure disease management in skilled nursing facilities (SNF Connect): Lessons learnedAndrea Daddato, Heidi L Wald, Carolyn Horney, et al.
British Journal of Clinical Pharmacology|January 1, 1983
Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trialJ J Belch, J Cormie, P Newman, et al.
Thrombosis and Haemostasis|June 30, 1981
Successful treatment of Raynaud's Syndrome with prostacyclinJ J Belch, P Newman, J K Drury, et al.
Journal of Lipid Research|April 18, 2003
Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistanceIsabel R Schlaepfer, Leslie K Pulawa, Luis D M C-B Ferreira, et al.
JACC. Basic to Translational Science|March 5, 2021
Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery DiseaseMinakshi P Biswas, Warren H Capell, Mary M McDermott, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2003
Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemiaWarren H Capell, Christopher A DeSouza, Paul Poirier, et al.
American Heart Journal|January 5, 2022
Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trialConnie N Hess, Warren H Capell, Michael R Bristow, et al.
The American Journal of Clinical Nutrition|January 29, 2010
Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate dietTeri L Hernandez, Julie P Sutherland, Pamela Wolfe, et al.
American Heart Journal|February 12, 2021
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD studyWarren H Capell, Elliot S Barnathan, Gregory Piazza, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Pain and Symptom Management|June 1, 2014
Ethical conduct of palliative care research: enhancing communication between investigators and institutional review boardsAmy P Abernethy, Warren H Capell, Noreen M Aziz, et al.
Clinical Trials (London, England)|February 1, 2017
A randomized trial of heart failure disease management in skilled nursing facilities (SNF Connect): Lessons learnedAndrea Daddato, Heidi L Wald, Carolyn Horney, et al.
British Journal of Clinical Pharmacology|January 1, 1983
Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trialJ J Belch, J Cormie, P Newman, et al.
Thrombosis and Haemostasis|June 30, 1981
Successful treatment of Raynaud's Syndrome with prostacyclinJ J Belch, P Newman, J K Drury, et al.
Journal of Lipid Research|April 18, 2003
Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistanceIsabel R Schlaepfer, Leslie K Pulawa, Luis D M C-B Ferreira, et al.
JACC. Basic to Translational Science|March 5, 2021
Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery DiseaseMinakshi P Biswas, Warren H Capell, Mary M McDermott, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2003
Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemiaWarren H Capell, Christopher A DeSouza, Paul Poirier, et al.
American Heart Journal|January 5, 2022
Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trialConnie N Hess, Warren H Capell, Michael R Bristow, et al.
The American Journal of Clinical Nutrition|January 29, 2010
Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate dietTeri L Hernandez, Julie P Sutherland, Pamela Wolfe, et al.
American Heart Journal|February 12, 2021
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD studyWarren H Capell, Elliot S Barnathan, Gregory Piazza, et al.
Pageof 8